Evogene (EVGN) News Today $1.29 -0.02 (-1.30%) Closing price 03:59 PM EasternExtended Trading$1.30 +0.00 (+0.15%) As of 05:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EVGN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New YorkAugust 28 at 7:00 AM | prnewswire.comEvogene Ltd. Reports Improved Revenue Amidst LossesAugust 20, 2025 | msn.comEvogene reports Q2 cont ops EPS (50c) vs. (85c) last yearAugust 19, 2025 | msn.comEvogene Announces Q2 2025 Financial Results and Strategic Shift to AIAugust 19, 2025 | msn.comEvogene Ltd. (EVGN) Q2 2025 Earnings Call TranscriptAugust 19, 2025 | seekingalpha.comEvogene Reports Second Quarter 2025 Financial ResultsAugust 19, 2025 | prnewswire.comEvogene Q2 2025 Earnings PreviewAugust 18, 2025 | msn.comEvogene (EVGN) Projected to Post Earnings on TuesdayAugust 18, 2025 | americanbankingnews.comEvogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic DiseasesAugust 12, 2025 | prnewswire.comEvogene Schedules Second Quarter 2025 Financial Results ReleaseJuly 29, 2025 | prnewswire.comEvogene Completes Sale of Lavie Bio’s Activities to ICLJuly 8, 2025 | tipranks.comEvogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICLJuly 8, 2025 | prnewswire.comEvogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google CloudJune 10, 2025 | prnewswire.comEvogene Ltd. Earnings Call: Balancing Growth and ChallengesMay 22, 2025 | tipranks.comEarnings call transcript: Evogene Reports Narrower Loss in Q1 2025May 22, 2025 | uk.investing.comEvogene Ltd (EVGN) Q1 2025 Earnings Call Highlights: Strategic Expense Reductions and Promising ...May 22, 2025 | finance.yahoo.comEvogene Ltd. Reports Q1 2025 Financial ResultsMay 21, 2025 | tipranks.comEvogene Ltd. (EVGN) Q1 2025 Earnings Call TranscriptMay 21, 2025 | seekingalpha.comEvogene Reports First Quarter 2025 Financial ResultsMay 21, 2025 | prnewswire.comEvogene Q1 2025 Earnings PreviewMay 20, 2025 | msn.comEvogene Schedules First Quarter 2025 Financial Results ReleaseMay 8, 2025 | prnewswire.comEvogene To Sell Majority Of Lavie Bio To ICL For Undisclosed TermsApril 23, 2025 | nasdaq.comWhy Evogene Ltd. (EVGN) Soared on MondayApril 22, 2025 | msn.comEvogene selling the activity of Lavie Bio subsidiary to ICLApril 21, 2025 | markets.businessinsider.comICL übernimmt Evogene-Tochter Lavie BioApril 21, 2025 | de.investing.comICL to Acquire the Activity of Evogene's Subsidiary, Lavie BioApril 21, 2025 | prnewswire.comEvogene Ltd. (NASDAQ:EVGN) Q4 2024 Earnings Call TranscriptMarch 10, 2025 | msn.comEvogene Ltd. (EVGN) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | seekingalpha.comEvogene Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 6, 2025 | prnewswire.comEvogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025March 6, 2025 | prnewswire.comEvogene Schedules Fourth Quarter 2024 Financial Results ReleaseFebruary 20, 2025 | prnewswire.comAgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat DiseaseFebruary 13, 2025 | prnewswire.comEvogene Ltd. Reschedules Special General Meeting Due to Lack of QuorumFebruary 5, 2025 | tipranks.comEvogene Ltd. (EVGN)January 25, 2025 | ca.finance.yahoo.comEvogene-Aktie erreicht 52-Wochen-Tief bei 1,25 US-DollarDecember 17, 2024 | de.investing.comEvogene-Aktie erreicht 52-Wochen-Tief bei 1,44 US-DollarDecember 5, 2024 | de.investing.comEvogene price target lowered to $5 from $12 at Lake StreetNovember 22, 2024 | markets.businessinsider.comEvogene Ltd. (EVGN) Q3 2024 Earnings Call TranscriptNovember 21, 2024 | seekingalpha.comEvogene Reports Third Quarter 2024 Financial ResultsNovember 21, 2024 | prnewswire.comLake Street Keeps Their Buy Rating on Evogene (EVGN)November 20, 2024 | markets.businessinsider.comEvogene Q3 2024 Earnings PreviewNovember 20, 2024 | msn.comA Glimpse of Evogene's Earnings PotentialNovember 20, 2024 | benzinga.comLavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial ResultsNovember 19, 2024 | prnewswire.comLavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field TrialsNovember 12, 2024 | prnewswire.comEvogene Schedules Third Quarter 2024 Financial Results ReleaseNovember 7, 2024 | prnewswire.comEvogene-Aktie erreicht 52-Wochen-Tief bei 2,13 US-DollarNovember 1, 2024 | de.investing.comEvogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule DesignOctober 31, 2024 | prnewswire.comCasterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in KenyaOctober 29, 2024 | prnewswire.comEvogene Ltd. (NASDAQ:EVGN) Short Interest Up 83.6% in OctoberOctober 26, 2024 | marketbeat.comEvogene (NASDAQ:EVGN) Stock Price Passes Below 200 Day Moving Average - Here's WhyOctober 25, 2024 | marketbeat.com Get Evogene News Delivered to You Automatically Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EVGN Media Mentions By Week EVGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVGN News Sentiment▼0.931.03▲Average Medical News Sentiment EVGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVGN Articles This Week▼21▲EVGN Articles Average Week Get the Latest News and Ratings for EVGN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Evogene and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CARM News Today SNES News Today TOMZ News Today BSLK News Today GURE News Today NITO News Today CNEY News Today TANH News Today DNMR News Today ICL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVGN) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access